ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
AQUABLATION: A SINGLE INSTITUTION EXPERIENCE OF 100 PATIENTS
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 248807" data-attributes="member: 13851"><p><strong>AQUABLATION: A SINGLE INSTITUTION EXPERIENCE OF 100 PATIENTS (2023)</strong></p><p><em>Dylan Dangerfield, MD, Yates Congleton, MD, Tanner Wright, MD, Wesley White, MD, Ryan Pickens, MD </em></p><p><strong>University of Tennessee at Knoxville, Department of Urology, Knoxville, TN, University of Tennessee at Knoxville, Department of Surgery, Knoxville, TN</strong></p><p><strong></strong></p><p><strong>Presented By: Ryan Baird Pickens, MD</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Introduction</strong></p><p></p><p><em><strong>Aquablation is a novel surgical approach for BPH that has shown noninferiority to TURP in the WATER I and WATER II trials while demonstrating a lower risk of sexual dysfunction. </strong>The majority of published literature includes smaller case series data. We report our initial data with 100 patients. </em></p><p></p><p></p><p><strong>Methods</strong></p><p></p><p><em><strong>In this single-center, single-surgeon study, 100 patients with moderate to severe LUTS related to BPH underwent Aquablation.</strong> The average age of men included was 71 years old.40 men had a history of urinary retention, 15 of whom required CIC preoperatively. Despite 87/100 (87%) of patients being on an alpha blocker, 5 alpha-reductase inhibitors, or combination therapy, the average preop IPSS score was documented as 28.8 with an average PVR of 327.3ml. The average prostate size was 123.6g (35-200g). IPSS and PVR were obtained at 6 weeks postoperatively and 6 months if available. Preoperative and 3-month postoperative PSA was also assessed. </em></p><p></p><p></p><p><strong>Results</strong></p><p></p><p><em><strong>100 men underwent Aquablation with average operative time (defined as TRUS insertion to foley catheter placement), average ablation time, and transurethral resection times as noted in Figure 1. IPSS scores and PVR trends over time are demonstrated in Figure 2.</strong> <strong><u>Average preoperative PSA recorded at 8 with an average of 75% reduction noted 3 months postoperatively</u>. </strong>Post-operative complications included 15 cases of urinary retention after initial foley catheter removal requiring CIC or replacement of indwelling foley catheter. Five patients required cystoscopy with clot evacuation and fulguration with 4 of the cases occurring in the first 40 cases before we adjusted our TUR technique. 10 of the 15 retention cases also occurred in the first 40 cases. <strong>No reports of de novo SUI or ED.</strong> </em></p><p></p><p></p><p><strong>Conclusion</strong></p><p><strong></strong></p><p><strong><em>Early data appears to demonstrate Aquablation as an effective treatment for BPH with a procedure duration of less than 1 hour for large prostates while obtaining significant IPSS and PVR improvement similar to other BPH procedures. There does not appear to be a significant risk of sexual dysfunction associated. </em></strong></p></blockquote><p></p>
[QUOTE="madman, post: 248807, member: 13851"] [B]AQUABLATION: A SINGLE INSTITUTION EXPERIENCE OF 100 PATIENTS (2023)[/B] [I]Dylan Dangerfield, MD, Yates Congleton, MD, Tanner Wright, MD, Wesley White, MD, Ryan Pickens, MD [/I] [B]University of Tennessee at Knoxville, Department of Urology, Knoxville, TN, University of Tennessee at Knoxville, Department of Surgery, Knoxville, TN Presented By: Ryan Baird Pickens, MD Introduction[/B] [I][B]Aquablation is a novel surgical approach for BPH that has shown noninferiority to TURP in the WATER I and WATER II trials while demonstrating a lower risk of sexual dysfunction. [/B]The majority of published literature includes smaller case series data. We report our initial data with 100 patients. [/I] [B]Methods[/B] [I][B]In this single-center, single-surgeon study, 100 patients with moderate to severe LUTS related to BPH underwent Aquablation.[/B] The average age of men included was 71 years old.40 men had a history of urinary retention, 15 of whom required CIC preoperatively. Despite 87/100 (87%) of patients being on an alpha blocker, 5 alpha-reductase inhibitors, or combination therapy, the average preop IPSS score was documented as 28.8 with an average PVR of 327.3ml. The average prostate size was 123.6g (35-200g). IPSS and PVR were obtained at 6 weeks postoperatively and 6 months if available. Preoperative and 3-month postoperative PSA was also assessed. [/I] [B]Results[/B] [I][B]100 men underwent Aquablation with average operative time (defined as TRUS insertion to foley catheter placement), average ablation time, and transurethral resection times as noted in Figure 1. IPSS scores and PVR trends over time are demonstrated in Figure 2.[/B] [B][U]Average preoperative PSA recorded at 8 with an average of 75% reduction noted 3 months postoperatively[/U]. [/B]Post-operative complications included 15 cases of urinary retention after initial foley catheter removal requiring CIC or replacement of indwelling foley catheter. Five patients required cystoscopy with clot evacuation and fulguration with 4 of the cases occurring in the first 40 cases before we adjusted our TUR technique. 10 of the 15 retention cases also occurred in the first 40 cases. [B]No reports of de novo SUI or ED.[/B] [/I] [B]Conclusion [I]Early data appears to demonstrate Aquablation as an effective treatment for BPH with a procedure duration of less than 1 hour for large prostates while obtaining significant IPSS and PVR improvement similar to other BPH procedures. There does not appear to be a significant risk of sexual dysfunction associated. [/I][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
AQUABLATION: A SINGLE INSTITUTION EXPERIENCE OF 100 PATIENTS
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top